Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)
Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)
Active, not recruiting · NCT07735039 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV) | Atypical Squamous Cells of the Cervix, DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Low-Grade Squamous Intraepithelial Lesions, Morphological and Microscopic Findings, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Squamous Intraepithelial Lesions, Tumor Virus Infections, Urogenital Diseases, cervix disorder, dysplasia of cervix, female reproductive system disorder, human papilloma virus infection, infectious disease, neoplasm, precancerous condition, sexually transmitted disease, uterine disorder, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not applicable | 2026-07-29 | NCT07735039 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dr. Lutfi Kirdar Kartal Training and Research Hospital | 12 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Health Sciences Turkey, Kartal Dr. Lütfi Kırdar City Hospital | Istanbul | Turkey (Türkiye) | 1 |